Table 5.
Ambulation
| N (%) | |
|---|---|
| Surveys | |
| y/n | 11 (65) |
| ECOG | 9 (53) |
| ODI | 6 (35) |
| mJOA | 2 (12) |
| GSTSG | 1 (6) |
| Nurick | 1 (6) |
| 4 step | 1 (6) |
| 10 meter | 1 (6) |
| Ongoing Clinical Trials | |
| ECOG/Zubrod | 15 (48) |
| y/n | 5 (16) |
Ambulation
| N (%) | |
|---|---|
| Surveys | |
| y/n | 11 (65) |
| ECOG | 9 (53) |
| ODI | 6 (35) |
| mJOA | 2 (12) |
| GSTSG | 1 (6) |
| Nurick | 1 (6) |
| 4 step | 1 (6) |
| 10 meter | 1 (6) |
| Ongoing Clinical Trials | |
| ECOG/Zubrod | 15 (48) |
| y/n | 5 (16) |